The effect of angiotensin II receptor antagonist on the exogenous erythropoietin requirement of haemodialysis patients
Open Access
- 1 August 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 14 (8) , 2047-2049
- https://doi.org/10.1093/ndt/14.8.2047
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- LOSARTAN, AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, REDUCES HEMATOCRITS IN KIDNEY TRANSPLANT RECIPIENTS WITH POSTTRANSPLANT ERYTHROCYTOSISTransplantation, 1997
- Benefit of angiotensin II receptor blockade in the treatment of posttransplant polycythemia in renal transplant recipientsTransplantation Proceedings, 1997
- Do ACE inhibitors influence the dose of human recombinant erythropoietin in dialysis patients?Nephrology Dialysis Transplantation, 1996
- Unresponsiveness to recombinant human erythropoietin in haemodialysis patients: possible implications of angiotensin-converting enzyme inhibitorsNephrology Dialysis Transplantation, 1996
- Enalapril treatment of posttransplant erythrocytosis: efficacy independent of circulating erythropoietin levelsAmerican Journal of Kidney Diseases, 1995
- Association of Post-Renal Transplant Erythrocytosis and Microalbuminuna: Response to Angiotensin-Converting Enzyme InhibitionAmerican Journal of Nephrology, 1995
- Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers.British Journal of Clinical Pharmacology, 1992
- MULTIPLE SITE ESTIMATES OF ERYTHROPOIETIN AND RENIN IN POLYCYTHEMIC KIDNEY TRANSPLANT PATIENTSTransplantation, 1990
- Physiological Studies of Erythropoietin in PlasmaPublished by Springer Nature ,1989
- Worsening of Anemia Induced by Long-Term Use of Captopril in Hemodialysis PatientsAmerican Journal of Nephrology, 1984